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http://Contents lists available at ScienceDirectEditorialIncreased intra-abdominal pressure in acute kidney injury: a cause
or an effect?The detrimental effects of increased intra-abdominal pressure
(IAP) on kidneys and other intra-abdominal organs have been
known for a long time, particularly in postoperative conditions [1].
In recent decades, the signiﬁcance of intra-abdominal hyperten-
sion (IAH) has been increasingly recognized because it is much
more prevalent than expected and is associated with increased
morbidity and mortality in critically ill patients [2]. Studies of
mixed populations in medical and surgical intensive care units
(ICUs) demonstrated a prevalence of IAH of up to 64% [3]. The
prevalence is higher in patients with septic shock, especially those
who received massive volume resuscitation [3]. The development
of IAH is associated with a worse clinical outcome. A large
multicenter epidemiological study found that new-onset IAH is
associated with a 1.85-fold increased risk of mortality in ICU
patients [4]. Moreover, studies that focused on the association
between IAH and acute kidney injury (AKI) demonstrated that IAH
was a good predictor of AKI in unselected ICU patients who
survived from shock and in patients who underwent liver
transplantation [5].
IAP in critically ill patients is normally 5–7 mmHg and
increases in situations of increased abdominal contents or
decreased abdominal wall compliance. IAH is deﬁned as a
sustained or repeated elevation of IAP of Z12 mmHg. Sus-
tained IAP of Z20 mmHg associated with new organ dysfunc-
tion constitutes abdominal compartment syndrome [2].
Abdominal perfusion pressure (APP) is a relatively novel
parameter that reﬂects the circulatory compromise and IAH
together. APP is calculated as the difference between the mean
arterial pressure and the IAP. Some studies have suggested that
APP may be superior to IAP in predicting patient outcome. The
maintenance of an APP of Z50 mmHg seems to provide
proper intra-abdominal circulation [6]. The most popular
technique for IAP measurement is transvesicular measure-
ment, i.e., the transduction of urinary bladder pressure
through an indwelling urinary catheter. The pressure in this
closed system can be measured either using a pressure
transducer in the ICU or by measuring the height of the ﬂuid
in the tubing in a non-ICU environment. Common practice for
the screening of patients at risk of IAH is the serial monitoring
of IAP every 4–6 hours [7].
An increased IAP level can negatively affect kidney function
indirectly (systemic effects) or directly (renal effects). Several132/$ - see front matter Copyright & 2015. The Korean Society of Nep
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dx.doi.org/10.1016/j.krcp.2015.05.001factors account for the effects of IAH on the cardiovascular
system. Firstly, IAH increases intrathoracic pressure, which is
reﬂected by cranial displacement of the diaphragm and results
in compression of the heart. Secondly, cardiac preload is
reduced via a decrease in venous return. Finally, systemic
afterload is increased through direct compression of vascular
beds. Ultimately, increased IAP induces a decrease of cardiac
output. Decreases in urine output and glomerular ﬁltration
rate were clearly observed in humans with experimentally
induced IAP. Directly measured renal vein pressure increased
from 5.8 mmHg to 18.3 mmHg and urine ﬂow was reduced by
half when the IAP was raised by external compression to
20 mmHg [8]. Given the low-pressure system of the postglo-
merular intrarenal vascular network, it is not surprising that
an IAP of 20 mmHg leads to signiﬁcant intrarenal venous con-
gestion and reduction of glomerular ﬁltration rate. AKI in heart
failure—the so-called cardiorenal syndrome—and hepatorenal
syndrome with ascites are other circumstances in which
increased renal venous pressure may contribute to the develop-
ment of AKI. Mullens et al [9] discovered that venous congestion
is the most important hemodynamic factor driving the worsening
of renal function in decompensated heart failure. The fact that
successful volume reduction, even in small amounts, is followed
by the recovery of kidney function in patients with cardiorenal
syndrome is a commonly observed phenomenon. Moreover,
some patients with hepatorenal syndrome exhibit diuresis and
improvement of azotemia after paracentesis, despite concerns
about hypovolemia. The precise role of IAH in hepatorenal
syndrome should be determined in future studies.
In this issue of the journal, Chang et al [10] prospectively
enrolled patients who were admitted to a medical ICU with
established AKI, and IAP was measured once a day for the ﬁrst
3 days. The authors used a standard transvesicular technique,
and the mean IAP levels were consistent over three measure-
ments. They discovered that IAH, deﬁned as a sustained elevated
IAP of Z12 mmHg, was highly prevalent (up to 79%) in ICU
patients with AKI. However, the presence of IAH was not
associated with the severity of AKI at the baseline. Furthermore,
IAH was not a predictor of AKI recovery or in-hospital mortality.
For several reasons, this article is recommended to nephro-
logists. Firstly, the article addresses the signiﬁcance of IAH as a
risk factor for, or cause of, AKI in critically ill patients. Given itshrology. Published by Elsevier. This is an open access article under the
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well-known nephrotoxic insults should be ascertained in
patients who develop AKI, particularly in ICU settings.
Nephrologists are apt to overlook the contribution of IAH to
AKI in clinical practice. Secondly, this paper elucidated the
association between AKI and IAH in a different manner from
previous studies showing that preceding IAH predisposed
critically ill patients to the development of AKI. In this study,
IAH was not related to either renal or patient outcome in
patients with established AKI. This suggests that IAH following
AKI is secondary to volume retention. In case of established
AKI, IAP would lose its prognostic power because the severity
of AKI was the most potent determinant of short-term renal
recovery. In contrast with previous epidemiological studies,
disease severity, as represented by a Simpliﬁed Acute Physiol-
ogy Score II (SAPS II), was the most potent predictor of
mortality in the study. Finally, there was another noteworthy
ﬁnding [10]; although the authors attributed little attention to
it. Among patients with AKI, baseline kidney function was
abnormal in most cases with normal IAP, whereas baseline
kidney function was normal in most cases with high IAP.
In other words, de novo AKI frequently involves IAH, whereas
acute-on-chronic kidney disease is seldom accompanied by IAH.
This distinction between AKI and acute-on-chronic kidney
disease warrants further investigation.
In conclusion, Chang et al [10] demonstrated that increased
IAP is highly prevalent in critically ill patients with AKI.
However, they failed to show that IAH was a prognostic factor
of renal or patient outcome in patients with established AKI,
suggesting that IAH following AKI is a secondary phenomenon.
Although it is generally accepted that increased IAP is an
important risk factor for AKI in critically ill patients, IAH
following AKI may have a different clinical signiﬁcance.Conﬂict of interest
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